12:07 25.08.2009, The Top 18 FAT Fighting Foods Patrick Tsakude LA Health August 2009
Increase your body's fat-burning power by eating these top-fat-fighting foods. #! Oatmeal, #2, Leafy Greens, #3 Olive oil, #4, Garlic, #5 Tomatoes, #6, Nuts #7, Cayenne, #8, Turmeric,
12:06 25.08.2009, Go Easy on the Salt Eduardo Pementa from Brisbane, Australia LA Health August 2009
People with high blood pressure that are not controlled by multiple medications are likely eating too much salt, new findings in the journal Hypertension show. Individuals with so-called
12:05 25.08.2009, Low-Calorie Diet Slows Aging Weindruch,Richard Science August 2009
A 20 year study of monkeys shows that a reduced-calorie diet pays of in less disease and longer life. Rhesus monkeys on strict, reduced-calorie diet were three times less likely to die from
12:03 25.08.2009, Diet Lowers Breast Cancer Risk bBefore Menaopause LA Health August 2009
Women who want to protect themselves from developing Breast cancer before menopause should be sure to eat their carrots, the results of new research suggest. Dr. Mignona of the Harvard
12:01 25.08.2009, New Stem Cell Rules Loosen Some Restrictions LA Health August 2009
The government released final rules last month, governing federally funded research on human embryonic stem cells, loosening some requirements that scientists said could have cost them a
10:26 09.08.2009, Who to consult people with HIV on treatment guidelines IAS Conference in Cape Town South Africa July 22, 2009
People living with HIV are to be consulted on the development of new World Health Organization treatment guidelines for low and middle-income settings, due to be released in November.
10:25 09.08.2009, Improved surveillance of cervical cancer recommended to populations with high HIV prevalence IAS meeting Cape town South Africa July 23-2009 South African Study
Cervical cancer prevention guidelines may need to be reviewed to address that particular needs of HIV infected women, due to poorer outcomes of treatment for predaceous cervical changes.
10:23 09.08.2009, Test and treat unlikely to halt Washington epidemic Harvard University Study
A mathematical model from the Harvard School of public Health, based on the population of Washington, DC has found that recalling every adult for annual HIV screening and treating every
10:22 09.08.2009, Experimental integrase inhibitor GSK-572 looks good in early studies
A second generation integrase inhibitor GlaxoSmithKline's S/GSK 1349572 or GSK-572 demonstrated very good activity in a 1O-day monotherapy study. This is good news.
14:59 07.08.2009, Boosted darunavir mono therapy works well in two studies Presented at the IAS conference in Cape town
Ritonavir-boosted darunavir alone maintains HIV suppression in most patients who achieved an undetectable viral load on combination antiretroviral therapy, according to two studies
14:58 07.08.2009, Anal cancer in men with HIV much more common in Post-HAART era: Nancy Crum-Cianflone of the US infectious disease Clinical Research Program
The annual incidence of anal cancer amongst people with HIV has continued to increase in recent years and now stands at 128 cases per 100,000 or one case in 784 people. This is nearly l00
14:58 07.08.2009, Boosted and unboosted atazanavir maintain viral suppression equally well
Unboosted atazanavir taken once daily as part of a combination antiretroviral regiment can keep viral load undetectable in patients who discontinue ritonavir.
14:56 07.08.2009, Kesho Bora study Maternal ART: during pregnancy and breastfeeding prevents more infections that short-course prophylaxis
Antiretroviral treatment for mothers started during pregnancy and continued throughout the breastfeeding period resulted in a significantly lower rate of mother-to-child transmission when
14:56 07.08.2009, Antiretrovirals and condoms will have more effect on HIV in south Africa than circumcision, model finds
In preliminary results from a mathematical model set up by researchers from the British Columbia Center for Excellence in HIV/AIDS, male circumcision was found to have a considerable lower
14:53 07.08.2009, Aciclovir reduces disease progression and death in people with HIV by nearly 20%. Presented at the IAS conference in Cape town South Africa July l9-22
HIV positive people given 400 mg of Aciclovir twice daily as part of a trial to see if the drug reduced HIV transmission in serodiscordant couples were l7% less likely to progress to AIDS, and
14:53 07.08.2009, Low bone-mineral density in Botswana PrEP trial participants raises concerns. IAS meeting Cape town July 22,2009
Researchers conducting a trial of tenofovir and FTC as pre-exposure prophylaxis in Botswana have found low bone mineral density levels in HIV negative volunteers at enrollment. The
14:52 07.08.2009, Antiretroviral roll-out results in major TB decline in South African study. Presented at the IAS conference
The roll-out of antiretroviral treatment to cover 90% of eligible people has resulted in a significant decline in new cases of TB in a South African township, demonstrating for the first
10:06 05.08.2009, Diabetes treatment goals are likely to be met in HIV+ patients Sept 1 edition of Clinical Infectious Diseases
Targets for the management of diabetes are as likely to be achieved in HIV-positive as HIV-negative individuals.
10:06 05.08.2009, Hepatitis C co-infection increases risk of many AIDS-defining illnesses. IAS conference July l9-22 Cape town South Africa Reported also in the August l5th edition of Clinical Infectious Diseases
HIV-positive patients who are co-infected with the Hepatitis C virus are twice as likely to develop an AIDS-defining illness than individuals who are only infected with HIV.
10:05 05.08.2009, Raltegravir moves closer to approval for first-line use in Europe
The integrase inhibitor raltegravir has taken a key step towards approval for use in first-line HIV therapy in Europe. The EMEA's Committee for Medicinal Products for Human Use has recommended
10:04 05.08.2009, Glaxo Smith Kline pharmaceutical company ledges 10 million to develop new HIV drugs for children
GSK has announced a package of new measures which aims to improve antiretroviral treatment for children and adults in sub-Saharan Africa
10:03 05.08.2009, HIV positive adolescents more likely to have poor language and writing skills
HIV-positive children and adolescents have poor language and reading skills. In a study published in AIDS-Patient Care and STD's, researchers showed that HIV-exposed but uninfected
10:00 05.08.2009, HIV rate could be higher in Black Americans because of less sexual mixing
From the San Francisco Department of Public Health presented at the IAS meeting in Cape Town South Africa. Researchers from San Francisco have published findings that they say support the
09:59 05.08.2009, Poor health and lack of support associated with HIV-related stigma presented at IAS Cape-town South Africa
High levels of stigma are experienced by people with HIV, and this is consistently associated wit lack of social support, poor physical and mental health, poverty and younger age, according
09:58 05.08.2009, RALTEGRAVIR (an integrase inhibitor) has been approved for the first-time in HIV treatment for treatment naive patients. It has been approved by regulatory authority in the US for people starting HIV treatment for the first time.
This is a very important break thru started for the first time in a long time by the US government.
09:57 05.08.2009, Poor CD 4 cell response to HIV treatment associated with increased risk death in Zambia
Published online in the June Journal of Acquired Immune Deficiency Syndrome Journal. Poor immunological response to HIV therapy 6 and l2 months after the initiation of therapy is
09:57 05.08.2009, Non-AIDS-defining illnesses Presented It the IAS meeting from the CASCADE cohort study presented in the IAS meeting in Cape town South Africa July l9-22
Over half the deaths observed in a large cohort of HIV-positive individuals in the combination antiretroviral therapy era, who were followed form seroconversion, were due to non-AIDS related
09:56 05.08.2009, Stopped doses reduces incidence and severity of efavirenz-related side-effects/ Annals of Internal Medicine August 4th edition
Gradually increasing efavirenz doses during the first two weeks of therapy with the drug reduces the incidence and severity of neuropsychiatric and sleep-related side-effects without
14:59 03.08.2009, Test
Test